TScan Therapeutics, Inc (TCRX) Announces Launch of Proposed Public Offering of Common Stock, Warrants
Go back to TScan Therapeutics, Inc (TCRX) Announces Launch of Proposed Public Offering of Common Stock, Warrants| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 7.29 -0.09 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.38 | 52 Week High | $26.80 | |||
| Open | $7.26 | 52 Week Low | $23.00 | |||
| Day High | $7.46 | P/E | N/A | |||
| Day Low | $7.04 | EPS | $0.00 | |||
| Volume | 107,072 | |||||
